277 related articles for article (PubMed ID: 24657153)
1. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
3. Progression markers of Spinocerebellar ataxia 2. A twenty years neurophysiological follow up study.
Velázquez-Perez L; Rodríguez-Labrada R; Canales-Ochoa N; Sanchez-Cruz G; Fernandez-Ruiz J; Montero JM; Aguilera-Rodríguez R; Diaz R; Almaguer-Mederos LE; Truitz AP
J Neurol Sci; 2010 Mar; 290(1-2):22-6. PubMed ID: 20070987
[TBL] [Abstract][Full Text] [Related]
4. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
[TBL] [Abstract][Full Text] [Related]
5. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
[TBL] [Abstract][Full Text] [Related]
6. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism.
Kim JM; Hong S; Kim GP; Choi YJ; Kim YK; Park SS; Kim SE; Jeon BS
Arch Neurol; 2007 Oct; 64(10):1510-8. PubMed ID: 17923635
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease.
Velázquez-Pérez L; Rodríguez-Labrada R; Cruz-Rivas EM; Fernández-Ruiz J; Vaca-Palomares I; Lilia-Campins J; Cisneros B; Peña-Acosta A; Vázquez-Mojena Y; Diaz R; Magaña-Aguirre JJ; Cruz-Mariño T; Estupiñán-Rodríguez A; Laffita-Mesa JM; González-Piña R; Canales-Ochoa N; González-Zaldivar Y
Cerebellum; 2014 Oct; 13(5):568-79. PubMed ID: 24906824
[TBL] [Abstract][Full Text] [Related]
8. Phenotype variability in spinocerebellar ataxia type 2: a longitudinal family survey and a case featuring an unusual benign course of disease.
Hering S; Achmüller C; Köhler A; Poewe W; Schneider R; Boesch SM
Mov Disord; 2009 Apr; 24(5):774-7. PubMed ID: 19224595
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2.
Simon DK; Zheng K; Velázquez L; Santos N; Almaguer L; Figueroa KP; Pulst SM
Arch Neurol; 2007 Jul; 64(7):1042-4. PubMed ID: 17620498
[TBL] [Abstract][Full Text] [Related]
10. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
11. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
[TBL] [Abstract][Full Text] [Related]
12. [Hereditary ataxias in Cuba. Historical, epidemiological, clinical, electrophysiological and quantitative neurological features].
Velázquez-Pérez L; García R; Santos FN; Paneque HM; Medina HE; Hechavarría PR
Rev Neurol; 2001 Jan 1-15; 32(1):71-6. PubMed ID: 11293106
[TBL] [Abstract][Full Text] [Related]
13. [Molecular analysis of the CAG repeat among patients with Type-2 spinocerebellar ataxia in the Mexican population].
Magaña JJ; Vergara MD; Sierra-Martínez M; García-Jiménez E; Rodríguez-Antonio F; Gómez Mdel R; Valdés-Flores M; Cisneros B
Gac Med Mex; 2008; 144(5):413-8. PubMed ID: 19043961
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of spinocerebellar ataxias in Cuba: insights into SCA2 founder effect in Holguin.
Velázquez Pérez L; Cruz GS; Santos Falcón N; Enrique Almaguer Mederos L; Escalona Batallan K; Rodríguez Labrada R; Paneque Herrera M; Laffita Mesa JM; Rodríguez Díaz JC; Rodríguez RA; González Zaldivar Y; Coello Almarales D; Almaguer Gotay D; Jorge Cedeño H
Neurosci Lett; 2009 Apr; 454(2):157-60. PubMed ID: 19429075
[TBL] [Abstract][Full Text] [Related]
15. [Clinico-genetic study of type I spinocerebelllar ataxia].
Svetel M; Culjković B; Sternić N; Dragasević B; Stojković I; Romac S; Kostić VS
Srp Arh Celok Lek; 1999; 127(5-6):157-62. PubMed ID: 10500422
[TBL] [Abstract][Full Text] [Related]
16. Spinocerebellar ataxia type 7: clinical course, phenotype-genotype correlations, and neuropathology.
Horton LC; Frosch MP; Vangel MG; Weigel-DiFranco C; Berson EL; Schmahmann JD
Cerebellum; 2013 Apr; 12(2):176-93. PubMed ID: 22915085
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2.
Velázquez Pérez L; Sánchez Cruz G; Canales Ochoa N; Rodríguez Labrada R; Rodríguez Díaz J; Almaguer Mederos L; Laffita Mesa J
J Neurol Sci; 2007 Dec; 263(1-2):158-64. PubMed ID: 17706249
[TBL] [Abstract][Full Text] [Related]
18. Role of glutathione S-transferases in the spinocerebellar ataxia type 2 clinical phenotype.
Almaguer-Gotay D; Almaguer-Mederos LE; Aguilera-Rodríguez R; Estupiñán-Rodríguez A; González-Zaldivar Y; Cuello-Almarales D; Laffita-Mesa JM; Vázquez-Mojena Y
J Neurol Sci; 2014 Jun; 341(1-2):41-5. PubMed ID: 24780439
[TBL] [Abstract][Full Text] [Related]
19. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.
Pulst SM; Santos N; Wang D; Yang H; Huynh D; Velazquez L; Figueroa KP
Brain; 2005 Oct; 128(Pt 10):2297-303. PubMed ID: 16000334
[TBL] [Abstract][Full Text] [Related]
20. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.
Van Damme P; Veldink JH; van Blitterswijk M; Corveleyn A; van Vught PW; Thijs V; Dubois B; Matthijs G; van den Berg LH; Robberecht W
Neurology; 2011 Jun; 76(24):2066-72. PubMed ID: 21562247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
